Skip to main content
iScience logoLink to iScience
. 2026 Sep 24;29(10):117293. doi: 10.1016/j.isci.2026.117293

Inverse directions of association of higher physical activity and higher insulin resistance with human skeletal muscle fiber-type gene expression

Dan L Ciotlos 1, Sarah C Hanks 1, Arushi Varshney 2, Michael R Erdos 3, Nandini Manickam 2, Heather M Stringham 1, Peter Orchard 2, Erin M Hill-Burns 1, Narisu Narisu 3, Lori L Bonnycastle 3, Michael D Sweeney 1, Jouko Saramies 4, Markku Laakso 5, Jaakko Tuomilehto 6, Timo A Lakka 7,8,9, Karen L Mohlke 10, Michael Boehnke 1, Francis S Collins 3,15, Heikki A Koistinen 11,12,13, Stephen CJ Parker 1,2,14, Laura J Scott 1,16,∗
PMCID: PMC13635265  PMID: 42835133

Summary

To investigate the interplay between physical activity and cardiometabolic traits in human skeletal muscle, we characterized gene expression and chromatin accessibility across skeletal muscle cell types in 263 Finnish individuals from the FUSION Tissue Biopsy Study. We analyzed single-nucleus RNA-seq data (168,309 nuclei), single-nucleus ATAC-seq data (242,069 nuclei), and bulk RNA-seq data. Lower insulin resistance (HOMA-IR) and higher total physical activity were both associated with higher proportions of Type 1 nuclei and lower proportions of Type 2x nuclei. Traits typically associated with better health—lower trait values of cardiometabolic traits such as HOMA-IR and higher physical activity levels—were associated with higher expression of energy metabolism genes and lower expression of signaling pathway genes across muscle fiber types, total pseudobulk, and to some extent in bulk tissue. HOMA-IR and physical activity appeared to have inverse and partially independent directions of association when adjusting for both traits in the same model.

Keywords: gene expression, chromatin accessibility, physical activity, insulin resistance, type 2 diabetes, single nucleus, skeletal muscle, snRNA-Seq, snATAC-seq

Graphical abstract

graphic file with name ga1.webp

Highlights

  • •

    Single-nucleus RNA-seq and ATAC-seq (omics) from 263 human skeletal muscle biopsies

  • •

    Omics associations with physical activity (PA) and insulin resistance (HOMA-IR)

  • •

    Inverse PA and HOMA-IR associations with cell type abundance and gene expression

  • •

    PA and HOMA-IR show partially independent associations with biological pathways


Musculoskeletal anatomy; Endocrinology; Physical activity; Human metabolism; Molecular biology; Transcriptomics

Introduction

Low physical activity levels and high insulin resistance are risk factors for type 2 diabetes (T2D); both risk factors influence and are influenced by the physiological state of skeletal muscle.1,2,3,4 A significant proportion of glucose disposal after an oral glucose load occurs in skeletal muscle, and insulin-stimulated glucose uptake is reduced in individuals with insulin resistance or a sedentary lifestyle.5,6 Regular physical activity improves skeletal muscle insulin sensitivity and reduces the risk of T2D.7,8 These physiological adaptations are mediated by skeletal muscle cell type abundance and gene expression within cells.

Skeletal muscle fiber type abundance varies by physical activity, degree of insulin resistance, and T2D status. In interventional studies, strength training is associated with a transition from fast-twitch, oxidative-glycolytic Type 2a and fast-twitch, glycolytic Type 2x muscle fibers to slow-twitch, oxidative Type 1 muscle fibers, although changes in fiber type abundance vary depending on the type of strength or endurance exercise performed.9,10,11 Normal glucose tolerance (NGT), as compared to T2D, is associated with higher proportions of Type 1 muscle fibers and lower proportions of Type 2x muscle fibers.12,13,14,15 These studies quantify cell type proportions by histochemical staining or fiber type-specific myosin heavy chain isoform expression, but provide no information on gene expression.

In analyses of bulk skeletal muscle, gene expression levels differ by physical activity, insulin resistance, and T2D status.10,16,17,18,19,20 Expression of mitochondrial function genes is widely reported to vary by T2D status. Individuals with NGT, as compared to those with T2D, show higher expression of cellular respiration genes.18,21 Participation in aerobic training is associated with higher expression of cellular respiration genes relative to an untrained baseline.10 Other biological processes, including protein modification and cell signaling, are also associated across these physiological states. Bulk muscle RNA-seq data measures exonic reads from both cytoplasmic and nuclear mRNA at the whole-tissue level.22 In contrast, single-nucleus RNA-seq (snRNA-seq) cell-type-level pseudobulk and total pseudobulk (all cell types combined) data capture exonic and intronic nuclear mRNA.23,24 These data types provide complementary perspectives on the relationship between gene expression and physiological traits; however, bulk RNA-seq studies may be confounded by individual differences in cell-type abundance and cannot identify cell-type-specific gene expression differences.25

Single-nucleus studies enable the quantification of cell-type abundance, cell-type-level gene expression, and cell-type-level chromatin accessibility. A small study in four humans found both shared and skeletal muscle fiber-type-specific differentially expressed genes and accessible chromatin regions in response to endurance exercise.26 Another study in 38 individuals identified differences in the transcriptional profiles of skeletal muscle fiber myonuclei, particularly Type 2a myonuclei, between individuals with and without T2D after 2-week high-intensity interval training.27 However, little is known about how insulin resistance affects gene expression or chromatin accessibility within specific skeletal muscle fiber types. Most bulk tissue and single-nucleus studies have focused on gene expression–trait associations for either physical activity or cardiometabolic traits, but few have investigated the association of both traits in the same individuals.

To investigate the interplay between physical activity and cardiometabolic traits in human skeletal muscle, we characterized gene expression and chromatin accessibility across skeletal muscle cell types in 263 Finnish individuals from the Finland-United States Investigation of NIDDM Genetics (FUSION) Tissue Biopsy Study. We analyzed skeletal muscle snRNA-seq data (168,309 nuclei, 23,849 genes), single-nucleus ATAC-seq (snATAC) data (242,069 nuclei, 927,588 peaks), and bulk RNA-seq data (22,309 genes). We tested for associations of physical activity and cardiometabolic traits, including body mass index (BMI), insulin resistance (Homeostatic Model Assessment of Insulin Resistance, HOMA-IR), and drug-naive T2D status (T2D vs. NGT), with cell-type abundance, cell-type-level and bulk tissue gene expression, and cell-type-level chromatin accessibility. We identified opposite and partially independent directions of association of higher physical activity and higher insulin resistance with skeletal muscle cell-type abundance and fiber-type-level gene expression.

Results

Vastus lateralis muscle biopsies

Our goal was to understand the pathways through which cardiometabolic and physical activity traits influence or are influenced by skeletal muscle gene expression or chromatin accessibility. We studied vastus lateralis biopsies from 263 Finnish individuals as part of the FUSION Tissue Biopsy Study.18 Insulin resistance was measured using HOMA-IR.28 Leisure time physical activity was assessed using a 12-month activity questionnaire.29,30,31 For analyses of cell type abundance, gene expression, and chromatin accessibility, we used a false discovery rate (FDR) threshold of <5% to define statistical significance.

Participants had a mean age of 60.3 ± 7.6 years, a mean BMI of 27.7 ± 4.2 kg/m2, and 43% were female (Table S1). 26.6% of participants had newly diagnosed, drug-naive T2D, 12.9% had impaired fasting plasma glucose (IFG), 24.7% had impaired glucose tolerance (IGT), and 35.7% had NGT.32 Individuals with T2D tended to have higher insulin resistance (HOMA-IR) than those with NGT (Figure S1), although some individuals with NGT had clinically high insulin resistance (HOMA-IR>2.9, as defined by da Silva et al.).33 Total and vigorous physical activity capture different aspects of energy expenditure, as some individuals reported high amounts of total physical activity despite engaging in little or no vigorous activity (Figure S2).

Cardiometabolic traits, including BMI, HOMA-IR, T2D status (T2D vs. NGT), and 2-hour plasma glucose, were positively correlated with each other (ρ range: 0.32 to 0.73); total and vigorous physical activity were positively correlated with each other (ρ = 0.58, p value = 1.5 × 10−24). 2-hour glucose was negatively correlated with vigorous physical activity (ρ = −0.20, p value = 1.3 × 10−3). HOMA-IR was not significantly correlated with either total physical activity (ρ = −0.11, p value = 0.07) or vigorous physical activity (ρ = −0.09, p value = 0.13) (Figure 1A); HOMA-IR also showed no significant associations with total physical activity (p value = 0.13) or vigorous physical activity (p value = 0.06) when adjusting for age and sex (Figure S2).

Figure 1.

Figure 1

Correlation of trait values and differences in cell type abundance in human skeletal muscle

(A) Heatmap of Spearman correlations of trait values across 263 individuals. Male vs. female and T2D vs. NGT variables were coded as binary (1 vs. 0). Physical activity is abbreviated as PHYS ACT. Bold values indicate correlations significantly different from 0 (Bonferroni-adjusted p value<0.05/28).

(B) UMAP projection of 410,378 snRNA-seq and snATAC-seq nuclei across 263 individuals. Each point is a nucleus, colored by cell type.

(C) Stacked bar plots showing cell type proportions per individual (n = 263), stratified by sex and insulin resistance level. The dashed line denotes the median Type 1 proportion per stratified group.

(D) Fold change and 95% confidence intervals comparing the number of snRNA-seq and snATAC-seq nuclei by trait, shown separately by cell type (left to right: total muscle fiber, Type 1, Type 2a, Type 2x, neuromuscular junction, smooth muscle, and neuronal; see Table S3 for full results). Models adjust for the total number of nuclei. Symbol shape denotes direction of association and fill indicates statistical significance (FDR<5%). See also Figures S1–S4 and Tables S1–S4.

Skeletal muscle cell type abundance

We analyzed 12 cell types, identified in jointly clustered skeletal muscle snRNA-seq (168,309 nuclei) and snATAC-seq (242,069 nuclei) nuclei (Figures 1B and S3).34 We visualized cell type abundance across males and females and stratified by HOMA-IR to examine across-person variability. On average, muscle fiber types made up 70% of the snRNA and snATAC nuclei (34% Type 1, 20% Type 2a, and 16% Type 2x) (Table S2). In bar plots of cell type proportions, individuals with clinically high insulin resistance (HOMA-IR>2.9) appeared to have a lower median proportion of Type 1 muscle fiber nuclei than individuals without insulin resistance (HOMA-IR ≤ 2.9) in both sexes (Figure 1C).

We used negative binomial models to test for associations between cell type abundance of snRNA and snATAC nuclei, and cardiometabolic and physical activity traits (Figure 1D; Table S3). Throughout this paper, we include results for sex for comparison to other traits (see Hanks et al. for a more extensive analysis of the association of sex in skeletal muscle).35 Males had a higher proportion of Type 2x (Fold change (FC) = 1.34, p value = 2.1 × 10−12) and lower proportions of Type 1 (FC = 0.88, p value = 4.4 × 10−6) and neuronal cell (FC = 0.87, p value = 4.4 × 10−6) nuclei than females. Higher BMI was associated with higher proportions of Type 2x (FC = 1.08, p value = 1.0 × 10−4) and neuromuscular junction (FC = 1.11, p value = 6.8 × 10−4) nuclei. Lower HOMA-IR and higher total physical activity (PA)—traits typically associated with better health—were both associated with higher proportions of Type 1 nuclei (HOMA-IR: FC = 1/0.96 = 1.04, p value = 1.0 × 10−3; Total PA: FC = 1.04, p value = 2.3 × 10−3) and lower proportions of Type 2x nuclei (HOMA-IR: FC = 1/1.09 = 0.92, p value = 1.7 × 10−5; Total PA: FC = 0.94, p value = 1.6 × 10−3). Higher HOMA-IR was associated with higher proportions of neuromuscular junction nuclei (FC = 1.14, p value = 2.5 × 10−5), while higher vigorous physical activity was associated with higher proportions of smooth muscle cell nuclei (FC = 1.05, p value = 2.0 × 10−3). For all traits and cell types, the directions of statistically significant cell type abundance–trait associations were consistent when analyzing nuclei from snATAC-seq or snRNA-seq separately (Figure S4).

The opposite directions of association with cell type abundance of Type 1 and Type 2x muscle fiber for higher HOMA-IR and higher total physical activity could reflect shared biology through independent mechanisms, or they could suggest that these traits influence one another. To help distinguish between these possibilities, we fitted regression models that included both HOMA-IR and total physical activity. Associations of HOMA-IR and total physical activity with cell type abundance had consistent fold change estimates and significance levels after joint adjustment (Figure S4). The adjusted and unadjusted fold change estimates in cell type abundance differed by <1.1% for Type 1 and Type 2x (Table S4). This indicates that the associations of insulin resistance and total physical activity with Type 1 and Type 2x muscle fiber nuclei abundance were not confounded by the other trait.

Gene expression–trait associations in skeletal muscle cell types, total pseudobulk, and bulk tissue

To explore how cardiometabolic and physical activity traits were associated with skeletal muscle gene expression, we tested for associations between physiological traits and gene expression using a negative binomial model across three data types: (1) cell-type-level pseudobulk data in the 10 most abundant muscle cell types, (2) total pseudobulk data, and (3) bulk RNA-seq data. For total pseudobulk and bulk muscle RNA-seq data, we adjusted for each sample’s observed single-nucleus cell type proportions to reduce confounding from inter-individual differences in cell type abundance. Across muscle fiber types, total pseudobulk, and bulk tissue, we found the highest number and percentage of associated genes for sex (male vs. female, 1974–7192 genes, 11.3–32.2% tested genes), followed by BMI (257–1377 genes, 1.5–6.2%), HOMA-IR (260–1955 genes, 1.5–8.8%), age (53–1275 genes, 0.2–5.7%), and vigorous physical activity (22–403 genes, 0.1–1.7%) (Figure 2A; Table S5).

Figure 2.

Figure 2

Gene expression–trait associations across cell types

(A) Number of significant (FDR<5%) genes for each trait across muscle fiber types, total pseudobulk, and bulk tissue (see Table S6 for full association results).

(B) Heatmap of Spearman correlations of signed (by beta coefficient) −log10 p values of gene expression–trait associations between cell types. The upper left triangle shows correlations for HOMA-IR and the lower right triangle for vigorous physical activity. Bold values indicate correlations significantly different from 0 (Bonferroni-adjusted p value<0.05/132).

(C, D, F, G, H) Scatterplots of signed −log10 p values of gene expression–HOMA-IR associations between two cell types. Images are shown as follows: (C) Type 2x vs. 2a, (D) Type 2x vs. 1, (F) total pseudobulk vs. Type 1, (G) bulk tissue vs. Type 1, and (H) bulk tissue vs. total pseudobulk. Axes correspond to the cell types named in each image (y axis vs. x axis). Each point is a gene, colored by significance category as indicated in the legend. All correlation coefficients (ρ) shown are significant with p value<10−200.

(E) Upset plot of the overlap of significant gene expression–HOMA-IR associations across muscle fiber types. Bars indicate the number of significant genes per cell type intersection. See also Figures S5–S12 and Tables S5, S6, S7, and S8.

For each trait, we typically found a larger number of associated genes in bulk tissue than in total pseudobulk, and in Type 1 fibers than in Type 2a or 2x fibers; we found few associations in the remaining cell types (Figure 2A; Tables S5 and S6). As the total number of unique molecular identifiers (UMIs) summed across all genes and individuals varies by cell type, we used total UMIs as a measure of statistical power (Figure S5). This measure accounts for both the number of nuclei and total levels of transcriptional activity that differ between cell types. To investigate whether differences in the number of gene expression–trait associations between Type 1 muscle fibers and other cell types were due to differences in power, we downsampled Type 1 muscle fibers to match the number of individuals and total UMIs in each cell type (see STAR Methods). Compared to the downsampled Type 1 fiber data, in Type 2a and 2x fibers we found more differentially associated genes for age, similar numbers for HOMA-IR, and fewer differentially associated genes for BMI and vigorous physical activity (Figure S6; Table S7). In other cell types, we found fewer differentially associated genes than in downsampled Type 1 fibers. These results suggest that HOMA-IR has a comparable influence on gene expression across all muscle fiber types, and that the higher number of associations initially observed in Type 1 fibers was driven by differences in statistical power; conversely, age appears to have a stronger influence on gene expression in Type 2a and 2x fibers relative to Type 1 fibers.

Comparison of gene expression–trait associations between skeletal muscle cell types, total pseudobulk, and bulk tissue

We next assessed if, for each trait, the same or different genes were associated with that trait across cell types, total pseudobulk, and bulk tissue. Identifying shared or distinct gene expression–trait associations could reveal cell-type-specific differential expression patterns that may be missed when gene expression is aggregated across cell types. We focused first on associations with HOMA-IR as this trait yielded more associated genes than T2D vs. NGT status (which includes a smaller proportion of the sample size), and because skeletal muscle plays a central role in the body’s response to insulin.6

Starting with the muscle fiber types, we observed strong, positive correlations of the signed (by beta coefficient) −log10 p values of gene expression–HOMA-IR associations between all muscle fibers, with the strongest correlation between Type 2a and 2x (ρ = 0.42, p value<10−200) (Figures 2B–2D and S7). We used an Upset plot to visualize the overlap of significantly associated genes with HOMA-IR in the three muscle fiber types (Figure 2E). A large proportion of genes were uniquely, significantly associated in a single fiber type (Type 1: 70% of all Type 1 associated genes, Type 2a: 49%, Type 2x: 45%). Among genes associated with exactly two fiber types, Type 2a and Type 2x shared the highest number of significantly associated genes (n = 75), followed by Type 1 and Type 2a (n = 54), and Type 1 and Type 2x (n = 11) (Figure 2E). 58 genes were significantly associated across all three muscle fiber types. Genes that were differentially expressed in more than one fiber type always had concordant directions of association (Table S8).

Compared to the strong, positive correlation of gene expression–trait associations between muscle fiber types, we found substantially weaker correlations of signed −log10 p values of gene expression–HOMA-IR associations between non-muscle-fiber cell types and any other cell type (all |ρ| < 0.08) (Figure S8). As an example, to test whether weaker correlations of Type 1 muscle fiber type with non-muscle fiber types reflect differences in statistical power to detect trait associations in the less abundant non-muscle-fiber cell types, we downsampled the Type 1 dataset to match the total UMI levels of those cell types (STAR Methods; Figure S9). When downsampled to match endothelial cell UMI levels, Type 1 retained strong correlations of 0.38 and 0.31 with Type 2a and Type 2x, respectively, whereas the original correlations between endothelial cells and Type 2a or Type 2x were near zero (all |ρ| < 0.02) (Figure S9). These results indicate that the stronger shared association patterns observed in muscle fiber nuclei were not solely due to differences in statistical power driven by high cell abundance. However, relative gene abundances were more similar among muscle fibers, which is not accounted for when downsampling total UMIs (Figure S10); this likely contributed to the stronger correlations among fiber types compared to non-muscle-fiber cell types.

We next compared cell-type-level gene expression–HOMA-IR association results to those observed in total pseudobulk and bulk tissue. Association results from the total pseudobulk dataset were most strongly correlated with Type 1 muscle fiber (ρ = 0.74, p value<10−200), followed by the other muscle fiber types (Figures 2B and 2F). This likely reflects the substantial contribution of muscle fibers, in particular Type 1 fiber, to total pseudobulk data. Similarly, bulk tissue was most strongly correlated with Type 1 muscle fiber (ρ = 0.32, p value<10−200) (Figures 2B and 2G). As expected, we found stronger correlations between cell-type-level results with total pseudobulk than with bulk tissue, potentially because total pseudobulk aggregates the same nuclei profiled at the cell type level and captures only nuclear mRNA.

We further compared gene expression–HOMA-IR associations between total pseudobulk and bulk tissue. Differences between the two data types may arise because nuclear and cytoplasmic mRNA are regulated differently or because the proportions of cell types captured in the single-nucleus experiment differ from those in the intact tissue. Of 115 significant gene expression–HOMA-IR associations in both total pseudobulk and bulk tissue, 114 (99%) had the same direction of association (Table S8). However, of the total 1569 significantly associated genes in bulk tissue also tested in total pseudobulk, only 1222 genes (78%, including non-significant total pseudobulk genes) had a concordant direction of association in total pseudobulk. Overall, gene expression–HOMA-IR associations were significantly positively correlated between total pseudobulk and bulk tissue (ρ = 0.34, p value<10−200) (Figure 2H); when only considering genes with high mean gene counts (counts>100) in both data types, we observed a stronger correlation (ρ: 0.41–0.68, Figure S11). This suggests a generally consistent pattern of gene expression–HOMA-IR associations between total pseudobulk and bulk tissue, particularly for genes highly expressed in both datasets. Likewise, we observed similar patterns of gene expression–vigorous physical activity associations between cell types, total pseudobulk, and bulk tissue (Figures 2B, S8, S9, and S12; Table S8).

Opposite directions of association with gene expression for higher HOMA-IR and higher physical activity

Previous bulk skeletal muscle tissue studies have reported that insulin resistance and physical activity were associated with sets of genes involved in energy metabolism and signaling pathways10,16,17,18,19,20; however, the extent to which these associations are identified in the same individuals and in specific muscle cell types remains unclear. To investigate this, we focused on vigorous physical activity as our trait of interest, as a larger proportion of genes were differentially expressed for vigorous physical activity than total physical activity. To compare the directions of association for gene expression–trait associations between HOMA-IR and vigorous physical activity, we plotted the signed (by beta coefficient) −log10 p values of associations between each trait in the muscle fiber types, total pseudobulk, and bulk tissue. We found that the signed −log10 p values of gene expression association results between vigorous physical activity and HOMA-IR were significantly negatively correlated in all muscle fibers, total pseudobulk, and bulk tissue (range ρ: −0.27 to −0.37) (Figures 3A, 3B, S13, and S14). Nearly all genes that are differentially expressed for both traits showed opposite directions of association for higher HOMA-IR and higher vigorous physical activity for each muscle fiber type (100% opposite association, n gene range: 5–56), total pseudobulk (100%, n = 14), and bulk tissue (94%, n = 69) (Table S9).

Figure 3.

Figure 3

Gene expression–trait associations across traits

(A and B) Scatterplots of signed (by beta coefficient) −log10 p values of gene expression–trait associations for HOMA-IR (y axis) vs. vigorous physical activity (VIG PHYS ACT, x axis), adjusting for base covariates only in (A) Type 1 muscle fiber (ρ = −0.35, p value<10−200) and (B) Type 2x muscle fiber (ρ = −0.33, p value<10−200). Each point is a gene, colored by significance category as indicated in the legend.

(C and D) Scatterplots of signed −log10 p values of gene expression–trait associations for HOMA-IR (y axis) vs. vigorous physical activity (VIG PHYS ACT, x axis) when jointly adjusting (adj.) for both traits in addition to base covariates in (C) Type 1 muscle fiber (ρ = −0.14, p value = 1.6 × 10−103) and (D) Type 2x muscle fiber (ρ = 0.03, p value = 4.1 × 10−5). Each point is a gene, colored by significance category as indicated in the legend.

(E) Heatmap of Spearman correlations of signed (by beta coefficient) −log10 p values of gene expression–trait associations between traits from models adjusting only for base covariates. The upper left triangle shows correlations for Type 1 muscle fiber and the lower right triangle for Type 2x muscle fiber. Bold values indicate correlations significantly different from 0 (Bonferroni-adjusted p value<0.05/224). The number of genes tested and sample sizes for each trait and cell type combination can be found in Tables S18 and S19. See also Figures S13–S19 and Table S9.

The opposite directions of association for gene expression results for HOMA-IR and vigorous physical activity could reflect shared biology through independent mechanisms, or they could suggest that these traits influence one another, leading to shared sets of associated genes. To evaluate the potential independence of these associations, we included both HOMA-IR and vigorous physical activity in the same regression model. Regression slopes of the log2 fold changes and signed −log10 p values of gene expression–trait associations before and after joint adjustment were consistently close to but less than 1 for HOMA-IR (range: 0.93–0.99) and vigorous physical activity (range: 0.92–0.99) across muscle fiber types, total pseudobulk, and bulk tissue (Figures S15–S18). This indicates a subtle attenuation of effect sizes and significance levels in the jointly adjusted traits. Specifically, the correlations of jointly adjusted HOMA-IR and vigorous physical activity gene expression–trait associations (signed −log10 p values) were attenuated relative to the unadjusted analyses, but remained negatively correlated in Type 1 (ρ = −0.14, p value = 1.6 × 10−103), Type 2a (ρ = −0.06, p value = 7.6 × 10−17), total pseudobulk (ρ = −0.12, p value = 8.8 × 10−64), and bulk tissue (ρ = −0.15, p value = 2.4 × 10−112), but not in Type 2x (ρ = 0.03, p value = 4.1 × 10−5) fibers (Figures 3C, 3D, and S13). This suggests partially independent associations with lower insulin resistance and higher vigorous physical activity for a subset of genes.

We hypothesized that other cardiometabolic traits would mirror the opposite directions of gene expression association results observed for HOMA-IR and physical activity. Consistent with our expectation, we found significant, negative correlations for gene expression–trait associations between cardiometabolic traits and physical activity traits in the muscle fiber types, total pseudobulk, and bulk tissue (ρ range: −0.13 to −0.42) (Figures 3E and S19). Similar, though weaker, negative correlations were observed in other non-muscle-fiber cell types with the exception of BMI and physical activity, which did not show a consistent pattern of correlation (Figure S19).

Opposite gene set directions of association for higher HOMA-IR and higher physical activity

Differences in gene expression associated with a cardiometabolic or physical activity trait may be coordinated, with multiple genes involved in a similar function or biological process showing concordant changes in expression. We performed Gene Ontology (GO) term enrichment analysis using RNA-Enrich36 to identify biological processes enriched for genes with positive or negative associations with these traits across cell types, total pseudobulk, and bulk tissue. Across muscle fiber types, total pseudobulk, and bulk, we found that bulk tissue had the greatest number of associated gene sets for every trait except for HOMA-IR, which was consistent with finding the most differentially expressed genes (DEGs) in bulk tissue (Figure 4A). Physical activity traits yielded the highest number of significant gene sets in Type 1 muscle fibers, while cardiometabolic traits yielded the most in Type 2a muscle fibers. Fewer than 35 significant gene sets were identified in any non-muscle-fiber cell types for any trait (Tables S10 and S11).

Figure 4.

Figure 4

Gene set–trait associations across traits

(A) Number of significant (FDR<5%) gene sets for each trait across muscle fiber types, total pseudobulk, and bulk tissue (see Table S11 for full association results). Gene sets tested are Gene Ontology biological processes (n = 6,486).

(B and C) Scatterplots of signed (by beta coefficient) −log10 p values of gene set–trait associations for HOMA-IR (y axis) vs. vigorous physical activity (x axis), adjusting for base covariates only, in (B) Type 1 muscle fiber (ρ = −0.59, p value<10−200) and (C) Type 2x muscle fiber (ρ = −0.61, p value<10−200). Each point is a gene set, colored by significance category as indicated in the legend.

(D and E) Scatterplots of signed −log10 p values of gene set–trait associations for HOMA-IR (y axis) vs. vigorous physical activity (x axis) when jointly adjusting (adj.) for both traits in gene expression models in (D) Type 1 muscle fiber (ρ = −0.44, p value<10−200) and (E) Type 2x muscle fiber (ρ = −0.39, p value<10−200). Each point is a gene set, colored by significance category as indicated in the legend.

(F) Heatmap of Spearman correlations of signed (by beta coefficient) −log10 p values of gene set–trait associations between traits from gene expression models adjusting only for base covariates. The upper left triangle shows correlations for Type 1 muscle fiber and the lower right triangle for Type 2x muscle fiber. Bold values indicate correlations significantly different from 0 (Bonferroni-adjusted p value<0.05/224). The sample sizes for each trait and cell type combination can be found in Table S19. See also Figures S20–S24 and Tables S10–S12.

Opposite directions of association with gene expression results for higher HOMA-IR and higher physical activity in muscle fiber types suggest that insulin resistance and physical activity might influence shared biological pathways. We compared gene set results for vigorous physical activity and HOMA-IR and observed significant, negative correlations between gene set–trait association results in Type 1 and 2x muscle fibers (Figures 4B and 4C), as well as Type 2a muscle fiber, total pseudobulk, and bulk tissue (ρ range: −0.61 to −0.30) (Figure S20). Consistent with these correlations, nearly all significant gene sets for both traits showed opposite directions of association for higher HOMA-IR and higher vigorous physical activity in each muscle fiber type (100% opposite association, n gene set range: 98–112), total pseudobulk (100%, n = 78), and bulk tissue (94%, n = 131) (Table S12).

To evaluate the potential independence of the gene set enrichment results for HOMA-IR and physical activity associations, we reran GO term enrichment analysis in each data type using the jointly adjusted gene expression–trait association data. Mirroring the gene-level results, the jointly adjusted HOMA-IR and vigorous physical activity gene set associations were attenuated but still significantly negatively correlated in all muscle fiber types, total pseudobulk, and bulk tissue (ρ range: −0.44 to −0.16) (Figures 4D, 4E, and S20). Most gene sets were significant for HOMA-IR or vigorous physical activity with and without jointly adjusting for the other trait in all muscle fiber types and bulk tissue (% range: 63–88%, Figures S21–S23); however, in total pseudobulk, only 33% of the originally significant gene sets were still significant for HOMA-IR after adjusting for vigorous physical activity.

Consistently, when comparing physical activity and other cardiometabolic traits within a cell type, we found significant, moderate, negative correlations of gene set results between cardiometabolic traits and physical activity traits in Type 1 and 2x muscle fibers (Figure 4F), as well as in Type 2a muscle fiber, total pseudobulk, and bulk tissue; and weaker negative correlations in other non-muscle-fiber cell types (Figure S24).

Higher expression of genes in energy metabolism-related gene sets associated with lower insulin resistance and higher physical activity

To better understand the cell-type-specific and trait-specific context of GO terms, we show results for seven GO terms across muscle fiber types, total pseudobulk, and bulk tissue (Figure 5A). Complete results for significant GO terms by trait are provided in the supplementary materials (Table S11). We observed far fewer significant GO term associations in non-muscle-fiber cell types.

Figure 5.

Figure 5

Selected significant Gene Ontology (GO) terms across data types and traits

(A) Gene set results for seven GO terms across traits and cell types (images arranged left to right: Type 1, Type 2a, Type 2x, total pseudobulk, and bulk tissue). Within each image, columns represent traits and rows represent GO terms. Color indicates odds ratios, and stars indicate significant gene set–trait associations (filled FDR<5%, unfilled p value<0.05).

(B) Histograms of the signed (by beta coefficient) −log10 p values of gene expression–trait associations for aerobic respiration genes. Columns correspond to traits (left to right: HOMA-IR, vigorous physical activity), and rows correspond to muscle fiber type (top to bottom: Type 1, Type 2a, Type 2x). Stars indicate significant aerobic respiration gene expression–trait associations for that trait in that cell type. Numbers indicate the percentage of genes with positive (red square) or negative (blue circle) gene expression–trait associations for the gene set.

(C and D) Scatterplots of the signed −log10 p values of gene expression–trait associations for HOMA-IR (y axis) vs. vigorous physical activity (x axis) for (C) aerobic respiration genes in Type 2x muscle fiber (ρ = −0.48, p value = 2.6 × 10−10) and (D) MAPK cascade genes in Type 1 muscle fiber (ρ = −0.46, p value = 3.8 × 10−29). Models are adjusted for base covariates only. Each point is a gene, colored by significance category as indicated in the legend. Arrows indicate the direction of association of the gene set–trait association from image A for each trait. Sample sizes for each trait and cell type combination can be found in Table S19. See also Figures S25–S34 and Table S13.

We first examined energy metabolism-related gene sets that have been widely reported to associate with T2D and physical activity in the literature.10,18 Across muscle fiber types, total pseudobulk, and bulk data, we observed higher expression of ATP biosynthetic process and aerobic respiration genes associated with higher physical activity (total and vigorous), lower 2-hour plasma glucose, younger age, and NGT compared with T2D (Figure 5A). We observed similar results across multiple energy metabolism-related gene sets (Figure S25A). In Type 2a and 2x fibers and in total pseudobulk, we observed lower expression of ATP biosynthetic process and aerobic respiration genes associated with higher HOMA-IR and higher BMI. In contrast, in bulk data, we observed higher expression of ATP biosynthetic process and aerobic respiration genes associated with higher HOMA-IR and BMI. To assess the sensitivity of bulk data analysis to the adjustment of estimated cell type proportions, we omitted cell type proportions from the model and reran the analysis. We found that energy metabolism-related gene sets tended to change their direction of association, showing lower expression associated with higher BMI or HOMA-IR when cell type proportions were not included (Figure S26). For other traits, we found consistent aerobic respiration gene set results in the adjusted and unadjusted analyses.

To assess the consistency of the gene expression–trait associations within gene sets, we calculated the proportion of genes with the same direction of association as the gene set results. In significantly associated aerobic respiration and ATP biosynthetic process gene sets, we observed that 57–90% of genes had gene expression–trait associations in the same direction as the gene set result (Figure S27). Across the three muscle fiber types, within significantly associated HOMA-IR and physical activity aerobic respiration gene sets, we found 62–65% of genes had directions of association consistent with the GO term direction of association, although ≤6 genes were significantly associated with either trait (Figure 5B).

To assess the effect of physical activity and insulin resistance traits on each other, we reran GO term enrichment analysis using the jointly adjusted gene expression–trait association data. The adjusted HOMA-IR and vigorous physical activity energy metabolism-related gene set associations were attenuated compared to unadjusted gene set analysis (in all but bulk data), but had the same direction of association and remained significantly associated (Figures S25B, S28, and S29). Thus, we observed partially independent associations of HOMA-IR and vigorous physical activity with these gene sets.

While the associations of HOMA-IR and vigorous physical activity with energy metabolism-related gene sets appear to be partially independent, this independence does not imply they affect these pathways through different mechanisms. These inverse associations may arise from a shared biological axis involving the same genes, or they may reflect distinct molecular signatures where different genes are associated with only one trait. To distinguish between these possibilities, we compared aerobic respiration gene expression–trait association results for vigorous physical activity and HOMA-IR in Type 2x muscle fibers. These associations were more strongly negatively correlated (ρ = −0.48, p value = 2.6 × 10−10) (Figure 5C) than the associations across all genes (ρ = −0.33, p value<10−200). Many of the significantly associated aerobic respiration genes for HOMA-IR (NDUFB8, MTFR1L) were among the most strongly associated (though not significant) with vigorous physical activity (Figure 5C); however, MLXIPL, the most significantly associated aerobic respiration gene for HOMA-IR, showed no association with vigorous physical activity. While HOMA-IR and physical activity were partially independent in our models, the inverse gene expression associations observed may reflect a primarily shared underlying biological axis involving a similar subset of aerobic respiration genes.

Enrichment differences for signaling pathways and other gene sets by trait

While energy metabolism gene sets are some of the most widely reported insulin resistance or physical activity-associated gene sets, we found a wide variety of significantly associated gene sets. Higher expression of branched-chain amino acid catabolic process genes was associated with lower HOMA-IR (in all muscle fiber types and total pseudobulk) and higher vigorous physical activity (Type 2x, total pseudobulk, and bulk tissue) (Figure 5A); we found similar directions of association across an expanded set of metabolic and catabolic processes gene sets relating to amino acids, lipids, nucleotides, and organic acids (Figure S30A).

The directions of association for the MAPK cascade gene set within muscle fibers and total pseudobulk were opposite to those observed for the aerobic respiration and branched-chain amino acid gene sets. Higher expression of MAPK cascade genes was associated with less favorable metabolic trait levels (higher BMI, higher HOMA-IR, T2D compared with NGT) and lower physical activity (total and vigorous), with statistically significant associations observed in Type 1 fibers and total pseudobulk (Figure 5A).

MAPK cascade gene expression–trait associations between vigorous physical activity and HOMA-IR in Type 1 were more strongly, negatively correlated (ρ = −0.46, p value = 3.8 × 10−29) than the associations across all genes (ρ = −0.35, p value<10−200) (Figure 5D). Our analysis highlights three distinct patterns of gene expression–trait associations within this pathway. First, three MAPK cascade genes (NPNT, ZFP36L1, and CDC42) were significantly associated with both higher HOMA-IR and lower vigorous physical activity (Figure 5D; Table S13). Second, many MAPK cascade genes were significantly associated with only one trait, but had an inverse direction of association that was slightly below the significance threshold for the other trait (DUSP10, FBXW7). Third, a subset of genes were significant for only one trait and had little to no evidence of association for the other. For example, higher expression of CD36 was significantly associated with higher HOMA-IR but showed no evidence of association with vigorous physical activity. Conversely, ST5 and IL26 were significantly associated with only vigorous physical activity. However, while many genes in the MAPK cascade reached significance for only one trait, it is not clear whether these sets of genes constitute a unique molecular signature or if the lack of significance reflects a small, coordinated shift of the same genes across the pathway that is not captured in this sample size at the single-gene level.

We found directions of association similar to the MAPK cascade across an expanded set of signaling pathway gene sets, though there was less consistency in the pattern of gene-set directions of association between total pseudobulk and bulk data for metabolic traits (Figure S31A). Similar to the MAPK cascade gene sets, we observed that higher expression of protein K48-linked ubiquitination (Type 1 and bulk tissue, Figure 5A), chromatin organization (Type 1, Type 2x, and total pseudobulk, Figure 5A), cytoskeleton organization (all muscle fiber types and total pseudobulk, Figure 5A), mRNA processing (Type 1, Figure S33A), and muscle structure development (all muscle fiber types and total pseudobulk, Figure S34A) genes were associated with higher HOMA-IR and lower vigorous physical activity. We found similar directions of association across related gene sets (Figures 5A, S32A, S33A, and S34A). We observed that, as for gene expression, most of the significant gene set–trait associations for HOMA-IR and vigorous physical activity were still significant when both traits were included in the same model (Figures 4D, 4E, S30B, S31B, S32B, S33B, and S34B). Overall, the directions of association for gene set–trait associations for higher HOMA-IR were similar to other cardiometabolic traits, including higher BMI, higher 2-hour plasma glucose, and T2D compared to NGT.

Chromatin accessibility–trait associations in skeletal muscle cell types

Gene expression is regulated in part by the extent of open, or accessible, chromatin at promoters and enhancers. To investigate how cardiometabolic and physical activity traits were associated with chromatin accessibility in twelve muscle cell types, we tested for association of cell-type-level chromatin accessibility (snATAC-seq data) with traits using a negative binomial model. Within each muscle fiber type, we found the highest number and percentage of differentially expressed peaks for sex (male vs. female, 36919–62206 peaks, 5.1–12.7%), and far fewer for BMI (1200–3194 peaks, 0.2–0.5%) and HOMA-IR (471–1882 peaks, 0.1–0.4%) (Tables S14 and S15). Overall, we observed >16 times more significant chromatin accessibility associations for sex than for other traits (Table S14; Figure S35).

To evaluate the relationship between chromatin accessibility and gene expression across muscle fiber types (Type 1, Type 2a, and Type 2x), we analyzed the frequency and directional concordance of trait-associated genes with trait-associated peaks located within promoter-proximal regions (1 kb upstream of the canonical transcriptional start site) (Figure S36). Of the tested genes in the three muscle fiber types, 58–62% had a called peak in the promoter-proximal region (Table S16). Across all fiber types, very few genes that were differentially expressed by trait had one or more differentially accessible promoter-proximal peaks (HOMA-IR (1.5–5.2%, n = 5–19) or vigorous physical activity (1.0–4.6%, n = 1–7)) (Table S16). For the small number of genes with differentially expressed promoter-proximal peaks, we observed substantial directional concordance between differential chromatin accessibility and gene expression among trait-associated genes (65–100% across traits and cell types) (Figure S36). As an example, in Type 2a muscle fibers, genes with at least one peak significantly associated with higher accessibility for lower HOMA-IR (n = 111) were 22.5 times more likely (p value = 1.52 × 10−29) to be significantly associated with higher gene expression for lower HOMA-IR, when compared to genes without such a peak (n = 19,172) (Figure S36; Table S16). However, a majority (>94.8%) of gene expression–trait associations occurred in the absence of detectable promoter-level peak–trait associations.

Discussion

This study highlights that muscle fiber type abundance and expression of energy metabolism genes exhibit inverse directions of association for higher insulin resistance and higher physical activity. While we cannot determine which differences are detrimental or causal for disease phenotypes, it is possible that physical activity could counteract muscle fiber type-specific gene expression patterns observed in individuals with insulin resistance.

The FUSION Tissue Biopsy Study integrates single-nucleus and bulk skeletal muscle tissue data from the same 263 individuals with detailed cardiometabolic and physical activity phenotyping. We identified numerous gene expression–trait and gene set–trait associations at the cell type level and tissue level (total pseudobulk and bulk tissue) for cardiometabolic and physical activity traits.

Overall, in single-nucleus data, lower values of cardiometabolic traits (BMI, HOMA-IR, NGT vs. T2D, and 2-hour glucose) and higher levels of both total and vigorous physical activity—traits typically associated with better health—showed similar directions of association with cell type abundance, as well as gene expression at the muscle fiber type and whole-tissue levels. For both HOMA-IR and physical activity, these directions of association persisted even after adjusting for the other trait. While insulin resistance pathways can be driven by physical inactivity,37 our results suggest that insulin resistance can act partially independent of physical activity on overlapping biological pathways.

Lower insulin resistance and higher total physical activity were associated with higher proportions of Type 1 nuclei and lower proportions of Type 2x nuclei, confirming findings from previous smaller single-nucleus experiments and histological studies.9,10,11,12,13,14,15 Higher proportions of Type 1 and lower proportions of Type 2x muscle fibers have previously been associated with healthier phenotypes, such as better metabolic function and increased fat utilization.38,39

Higher expression of energy metabolism genes was associated with lower cardiometabolic trait levels (BMI, HOMA-IR, NGT vs. T2D, 2-hour plasma glucose) and higher physical activity levels (total and vigorous) across muscle fiber types and in total pseudobulk data. By examining the genes within this and other pathways, we found that even though the traits appeared to have partially independent gene expression associations, they affected a shared underlying biological axis, as the traits were associated with similar subsets of genes within each respective pathway. The association of cardiometabolic and physical activity traits with energy metabolism-related gene set pathways was characterized by small, coordinated shifts across entire pathways rather than strong associations of singular genes. This finding mirrors results in other studies of Type 2 diabetes, where a pathway is significant despite having few, if any, genes that pass significance thresholds.18,21

Overall, we also identified similar, shared gene expression–trait and gene set–trait associations across all muscle fiber types, from the oxidative Type 1 fibers to the glycolytic Type 2x fibers, for both insulin resistance (HOMA-IR) and vigorous physical activity. However, a substantial proportion of associated genes were significant in only one fiber type, highlighting potential nuances in the gene expression patterns that occur between similarly functioning, but highly specialized, muscle fiber types. We identified minimal sharing of gene expression–trait associations between non-muscle fiber cell types and muscle fiber types. Differences in gene expression–trait associations across cell types may reflect varying statistical power rather than true biological differences. To account for this, we downsampled Type 1 fiber data to match the total UMI counts of each of the other cell types and continued to see strong correlations of Type 1 fiber data with Type 2a and Type 2x muscle fiber types. While we equalized UMI counts, the inherently similar expression profiles among muscle fiber types likely led to higher concordance of association results compared to non-muscle fiber types.

Gene expression–trait associations for HOMA-IR and vigorous physical activity in individual muscle fiber types mostly mirrored the associations identified in total pseudobulk and bulk data, and in previously published bulk data.10,16,17,18,19,20 Gene expression–trait associations between single-nucleus total pseudobulk (nuclear RNA) and bulk tissue (cellular RNA) datasets were most similar for genes more highly expressed in both data types, suggesting nuclear and cellular results will become more consistent as sample sizes increase. In addition, some differences in association results between total pseudobulk and bulk tissue may reflect differences in the relative abundance of cell types between the two data types or trait-specific regulation of nuclear versus cytoplasmic mRNA.40,41,42 For example, energy metabolism-related gene set associations showed similar directions of association between total pseudobulk and bulk tissue for physical activity and T2D status; however, for BMI and insulin resistance (HOMA-IR), directions of association in bulk tissue were opposite those identified in the muscle fiber types and total pseudobulk, and contrary to previously published bulk RNA-seq experiments.18 In contrast to the bulk RNA-seq results in Scott et al.,18 our study adjusted for single-nucleus cell type proportions inferred from single-nucleus data, which may account for some of these differences. Skeletal muscle bulk tissue studies remain valuable for identifying gene expression associations that are consistent across muscle fiber types, but results may be influenced by differences in cell type abundance, especially for traits with cell-type-specific expression patterns.

In contrast to gene expression–trait associations, we identified a smaller proportion of cell-type-level chromatin accessibility–trait associations for cardiometabolic and physical activity traits, especially when compared to sex. Given that our study was sufficiently powered to identify significant sex-biased peaks, the lower proportion of associations for other traits likely reflects biology rather than solely limitations in statistical power. This contrast suggests that sex exerted a comparatively stronger influence on skeletal muscle chromatin organization, while the associations with cardiometabolic and physical activity traits were more limited. We also found that >94% of genes differentially expressed for HOMA-IR or vigorous physical activity did not have detectable promoter-level peak–trait associations in muscle fiber types. This suggests that differences in promoter-proximal chromatin accessibility may play a relatively minor role in the regulation of gene expression in the context of cardiometabolic and physical activity traits. The absence of promoter-proximal peaks for 38–42% of all genes in the muscle fiber types could be due to assignment of the wrong promoter to the gene or because the peak was below our detection threshold. Our findings are consistent with Kiani et al. (2022), who found that gene expression changes can occur without shifts in local chromatin accessibility, potentially through binding of regulatory transcription factors to pre-existing, accessible chromatin regions.43

Limitations of the study

The skeletal muscle biopsies in the FUSION Tissue Biopsy Study were obtained from older, Finnish individuals (mean age: 60.3 years), with >98% of participants older than 45 years of age. Thus, the results cannot be generalized to younger individuals. However, older individuals are at a greater risk for insulin resistance and, ultimately, T2D.44,45 As older individuals typically have lower levels of physical activity than younger individuals, the observed range of physical activity may influence gene expression.46,47 We used self-reported physical activity, developed and validated in observational studies among Finnish adults. As such, we cannot assess the interventional effects of physical activity on gene expression at the cell type and bulk tissue level. However, the cell-type-level gene expression–physical activity associations observed in our study recapitulate previously reported associations of energy metabolism gene sets from small-scale interventional single-nucleus studies and bulk tissue studies.10,26,27 Our study was enriched for individuals with newly diagnosed, drug-naive T2D, and thus the results may not be fully representative of the general population. Their inclusion allowed us to test for differences between individuals with T2D and those with NGT. We were not able to perform direct replication of our results as we did not identify other single-nucleus skeletal muscle datasets that included measurements of insulin resistance, T2D status, and physical activity within the same individuals. Our data can serve as a well-phenotyped atlas of skeletal muscle.

Furthermore, we did not perform a formal mediation analysis to determine if the effects of physical activity occur through changes in insulin sensitivity. In our cohort, the association between vigorous physical activity and HOMA-IR was not significant (p value = 0.06 adjusting for age and sex), which limits the statistical power to separate the association into direct and indirect effects, and increases the risk of Type II errors.48,49 Consequently, we used jointly adjusted models to demonstrate the partial independence of these two traits; larger cohorts will be required to distinguish the magnitude of their mediated versus independent effects.

Our results do not establish causal links between differences in cardiometabolic or physical activity traits and differences in gene expression levels. While RNA is the active form of some genes, the majority of genes exert their biological effects through their protein products.50 Protein isoforms can have distinct biological functions, and differences in protein levels can alter the activity of biological processes.51,52 Although changes in gene expression may not be causal for disease, they can indicate a deviation from an optimal or healthy cellular state. Gene expression profiles are tightly regulated, and perturbation or misregulation may contribute to disease development.53 For example, we found that higher expression of MAPK cascade genes was associated with higher insulin resistance and lower vigorous physical activity across muscle fiber types and in total pseudobulk. While higher expression of these genes does not imply a disease state, it does suggest that the MAPK pathway may be perturbed; misregulation of MAPK signaling has been linked to increased risk of both cancer and diabetes.54 These findings enhance our understanding of the complex interplay between physical activity and insulin resistance in shaping skeletal muscle abundance and muscle fiber type-specific gene expression, and highlight a potential benefit of regular physical activity.

Resource availability

Lead contact

Requests for further information and resources should be directed to and will be fulfilled by the lead contact, Laura J. Scott (ljst@umich.edu).

Materials availability

This study did not generate unique reagents.

Data and code availability

  • •

    The bulk RNA-seq, snRNA-seq, snATAC-seq, and phenotype data have been deposited in dbGaP: phs001048.v4.p1 and are publicly available as of the date of publication. All original code and an extended Table S15 with all peak–trait association results have been deposited to Zenodo and are available as of the date of publication: https://doi.org/10.5281/zenodo.17742578.

  • •

    Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.

Acknowledgments

The samples/data used for the research were obtained from THL Biobank (study number THLBB2025_5). We thank all study participants for their generous participation in Finnish health research. This work was supported by the National Institutes of Health grants T32HG000040 (NHGRI) to M.B. (D.L.C., S.C.H., and M.D.S. supported), R01DK072193 (NIDDK) to K.L.M., UM1DK126185 (NIDDK) to K.L.M. and S.C.J.P., U01DK062370 (NIDDK) to M.B. and L.J.S., R01HG009976 (NHGRI) to M.B., R01DK117960 (NIDDK) to S.C.J.P., and P30AR069620 (NIAMS) to S.C.J.P., and by the Foundation for the National Institutes of Health (FNIH) grant N033979 to S.C.J.P. and L.J.S. The graphical abstract was created in BioRender: https://BioRender.com/jkosjdf.

Author contributions

Conceptualization, D.L.C., A.V., S.C.J.P., and L.J.S.; study design, M.R.E., J.S., M.L., J.T., T.A.L., M.B., F.S.C., H.A.K., S.C.J.P., and L.J.S; data curation, A.V., M.R.E., N.M., H.M.S., P.O., N.N., L.L.B., and M.D.S.,; formal analysis, D.L.C. and S.C.H.; funding acquisition, M.L., J.T., T.A.L., K.L.M., M.B., F.S.C., H.A.K., S.C.J.P., and L.J.S.; investigation, D.L.C., S.C.H., A.V., M.R.E., N.M., H.M.S., E.M.H-B., N.N., L.L.B., and M.D.S.; methodology, D.L.C., S.C.H., A.V., P.O., M.D.S., and L.J.S.; visualization, D.L.C.; supervision, S.C.J.P. and L.J.S.; writing – original draft, D.L.C. and L.J.S.; writing – review and editing, D.L.C., S.C.H., H.M.S., E.M.H-B., J.T., T.A.L., M.B., H.A.K., and L.J.S.

Declaration of interests

S.C.J.P. has a Pfizer grant. J.T. is a shareholder in Orion Pharma, Aktivolabs LTD, and Digostics LTD. E.M.H-B.'s spouse is an employee and shareholder of GE HealthCare.

STAR★Methods

Key resources table

REAGENT or RESOURCE SOURCE IDENTIFIER
Deposited data

FUSION bulk RNA-seq Scott et al.18 dbGaP: phs001048.v4.p1
FUSION single-nucleus RNA-seq and ATAC-seq Varshney et al.34 dbGaP: phs001048.v4.p1
Phenotypes This paper dbGaP: phs001048.v4.p1
Gene annotations GENCODE v3055 https://www.gencodegenes.org

Software and algorithms

DESeq2 Love et al.56 https://doi.org/10.18129/B9.bioc.DESeq2
RNA-Enrich Lee et al.36 http://lrpath-db.med.umich.edu
Analysis code This paper https://doi.org/10.5281/zenodo.17742578

Experimental model and study participant details

FUSION Tissue Biopsy Study

The Finland-United States Investigation of NIDDM Genetics (FUSION) Tissue Biopsy Study enrolled 331 living Finnish participants from three study sites in Finland (Helsinki, Kuopio, and Savitaipale) between 2009 and 2013. Clinical phenotyping was conducted during a clinical study visit that occurred on average two weeks (SD: 15 days) before the biopsy visit. During the biopsy visit, ∼250 mg of vastus lateralis skeletal muscle tissue was collected from each participant. Further study details can be found in Scott et al.18

Following participant and quality control exclusions (as described in method details), the final sample set included 263 participants with Finnish ancestry (mean age: 60.3 ± 7.6 years, 43% female). We included sex as a covariate in all statistical models to account for biological sex differences.

The FUSION Tissue Biopsy Study was approved by the coordinating ethics committee of the Hospital District of Helsinki and Uusimaa, and the University of Michigan Institutional Review Board (HUM00149138). All participants provided written informed consent.

Glucose tolerance status

During the clinical visit, after a 12-hour overnight fast, participants underwent a 2-hour, 4-point oral glucose tolerance test with fasting serum insulin also measured. We characterized an individual’s glycemic status as normal glucose tolerance (NGT), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or type 2 diabetes (T2D), using the WHO diagnostic classification.32 Individuals with T2D were newly diagnosed and were not using glucose-lowering drugs. We approximated insulin resistance using the HOMA-IR method (Homeostatic Model Assessment for Insulin Resistance).28

Leisure time physical activity

Participants completed a validated 12-month leisure time physical activity history questionnaire that included the most common types of physical activity among Finnish adults.29,30,31 For each activity, participants reported the mean intensity (on a scale ranging from light to very heavy), average duration of each physical activity session, and frequency per month. The energy expenditure of each activity was defined as the metabolic equivalent of task (MET) value for each intensity value based on empirical data. The weekly duration (hr/wk) of each activity was calculated as the product of the average weekly frequency and the average duration of the activity. The energy expenditure of each activity (METS×kg×hr/wk) was calculated as the product of the weekly duration (hr/wk), body weight of the participant (kg), and the MET value assigned to that activity. Total weekly energy expenditure (TOTAL PHYS ACT) was calculated as the sum of energy expenditures for all activities. Weekly energy expenditure from vigorous activities (VIGOROUS PHYS ACT) was calculated as the sum of energy expenditures of activities with MET values ≥6, corresponding to vigorous-intensity physical activity as defined by the Compendium of Physical Activities.57

Method details

Single-nucleus RNA-seq and ATAC-seq

The FUSION Tissue Biopsy Study skeletal muscle snRNA-seq and snATAC-seq datasets were generated as described in Varshney et al. (2024) and are available in dbGaP.34 Briefly, we performed single-nucleus RNA-seq (snRNA-seq) and single-nucleus ATAC-seq (snATAC-seq) (on separate nuclei from the same isolation) in 287 frozen muscle tissue biopsy samples, processed in 10 batches. snRNA-seq reads were mapped using STARsolo58 and snATAC-seq reads were mapped using the Burrows-Wheeler Aligner (BWA-MEM)59 to the human genome (hg38) reference. After applying droplet-level quality control thresholds, there were 180,583 RNA-seq nuclei and 268,543 ATAC-seq nuclei across all samples. Ambient RNA decontamination for snRNA-seq droplets was carried out with DecontX.60 We used Liger’s online iterative non-negative matrix factorization (iNMF) algorithm61,62 to jointly cluster snRNA-seq and snATAC-seq nuclei. We first factorized snRNA nuclei using autosomal protein-coding gene counts. We then projected the snATAC nuclei onto this RNA factorization using gene activity scores calculated using gene fragment counts (gene body + 3kb promoter region). The gene loadings created during the RNA factorization were then used to calculate the factor loadings for the ATAC nuclei. This allowed for the joint clustering of nuclei. By using chromatin accessibility as a proxy for transcriptional potential, it provides a common feature for joint clustering and factorization; however, as these inferred measures do not account for mRNA nuclear stability or enhancer effects, they were used strictly for cross-modality integration.

We used known cell type markers to identify the clusters as adipocyte (ADIPOQ), endothelial cell (VWF), macrophage (CD163), fibro-adipogenic progenitor cell (FBN1), mixed muscle fiber (MYH1, MYH2, MYH7), neuromuscular junction (muscle fiber) (CHRNA1), neuronal cell (GRIA2), satellite cell (PAX7), smooth muscle cell (ACTA2), T cell (SKAP1), Type 1 muscle fiber (MYH7), Type 2a muscle fiber (MYH2), and Type 2x muscle fiber (MYH1) (Figure S37). We removed the mixed muscle fiber type cluster from further analyses due to overrepresentation of exonic reads.34 We also excluded samples (a) with <100 snRNA-seq nuclei or <100 snATAC-seq nuclei (n = 2), (b) from one non-Finnish individual, (c) from one individual from each of two first-degree relative pairs, and (d) from individuals who did not consent to be included in the Terveyden ja Hyvinvoinnin Laitos (THL) Biobank (n = 19). After exclusions, we retained 168,309 snRNA-seq nuclei and 242,069 snATAC-seq nuclei from 263 participants.

As described in Varshney et al. (2024), ATAC peak calls from each cluster were harmonized to create a list of consensus peak summits across cell types by 1) calling narrow peaks within each cluster using MACS2 and merging the peak summit calls, and 2) sequentially collapsing peak calls within 150bp windows and retaining the summit of the peak with the most significant MACS2 q value (consensus peak).34,63,64 In each nucleus, reads within 150bp of the consensus peak summits were assigned to the peak.

Bulk RNA-seq

Detailed methods for sample collection, processing, and quality control for bulk RNA-seq can be found in Scott et al.18 Briefly, total RNA from 301 frozen muscle tissue biopsy samples was sequenced to a mean depth of 91.3M strand-specific paired-end reads per sample.

Quantification and statistical analysis

Differential cell type abundance by phenotypic traits

We tested for associations between cell type proportions and sex (male vs. female, n = 263), BMI (n = 263), HOMA-IR (n = 263), 2-hour glucose (n = 262), T2D vs. NGT (n = 164), total physical activity (n = 262), and vigorous physical activity (n = 262) in three sets of nuclei: snRNA-seq, snATAC-seq, and combined snRNA-seq + snATAC-seq datasets. For each cell type and for the combined muscle fiber types (1 + 2a + 2x), we used negative binomial models to test the association between the number of nuclei and each trait using the glm.nb() function from the MASS package (version 7.3-65).65 We adjusted for sex, age, batch, and city of collection, and included the log10 number of total nuclei as an offset in all models. We inverse normalized all continuous traits to reduce the effect of extreme values. To assess potential confounding, we tested models adjusting for both HOMA-IR and total physical activity. We corrected for multiple testing by applying a false discovery rate (FDR) threshold of 5% across all trait–cell type associations within each set of nuclei.

Single-nucleus cell type differential gene expression by phenotypic traits

We tested single-nucleus cell-type-level gene expression data for association with continuous cardiometabolic traits, physical activity, sex (male vs. female), age, and T2D vs. NGT. To create cell-type-level pseudobulk counts, for each participant we summed the UMI counts for each gene across all nuclei of a cell type. We excluded genes with zero counts for more than 75% of samples by cell type. For each cell type, we excluded samples with <10 snRNA nuclei of that cell type. We excluded adipocytes and T cells from the analysis for all traits, and macrophage and neuronal cells from the analysis of T2D status as fewer than 25 samples had at least 10 nuclei. Across cell types, the number of samples with ≥10 snRNA nuclei ranged from 2 in T cells to 263 in Type 1 (Table S17). The mean number of snRNA nuclei per sample ranged from 12.5 in T cells to 258.0 in Type 1 (Table S17). The number of genes tested ranged from 11,490 to 23,849 (Table S18).

For each cell type, we used a negative binomial model to test for the association between gene expression counts and a trait. Sample size varied across models depending on trait availability (Table S19). We ran the analysis using DESeq2 (version 1.44.0) with the single cell recommendations (likelihood ratio test and setting the minmu parameter to 1×10-6).56 We adjusted for batch, city of collection, median mitochondrial fraction (across nuclei), total number of RNA nuclei, sex, and age. To test for confounding, we included additional models adjusted for both HOMA-IR and vigorous physical activity. We inverse normalized all continuous covariates to remove the possible effect of extreme values. We corrected for multiple testing by applying an FDR threshold of 5% across all gene expression–trait associations for a given trait and cell type. No independent filtering was performed when using DESeq2.

Single-nucleus pseudobulk differential gene expression by phenotypic traits

For each individual, we created total pseudobulk counts by summing the UMI counts for each gene across all nuclei. We excluded genes with <5 counts in >75% of the samples, and retained all samples with ≥100 nuclei. This filtering results in 18,618 genes tested in 263 samples with a mean number of 635.3 nuclei per sample (Tables S17 and S18).

We used a negative binomial model to test for associations between gene expression counts and each trait. Sample size varied across models depending on trait availability (Table S19). Because these gene expression data were less sparse than those at the cell type level, we conducted the analysis using DESeq2 (version 1.44.0), following bulk RNA recommendations (Wald test instead of likelihood ratio test).56 Models were adjusted for the observed cell type proportions and covariates used in the cell-type-level analysis. To assess potential confounding, we also ran additional models, adjusted for both HOMA-IR and vigorous physical activity. We corrected for multiple testing by applying an FDR threshold of 5% across all gene expression–trait associations for a given trait. No independent filtering was performed when using DESeq2.

Bulk tissue differential gene expression by phenotypic traits

To enable direct comparisons with total pseudobulk data, we restricted the bulk RNA-seq dataset to samples that were included in the single-nucleus analysis. We excluded genes with <5 counts in >75% of the samples, resulting in 22,309 genes tested in 252 samples (Table S18).

We used a negative binomial model to test for the association between bulk gene expression counts and each trait. Sample size varied across models depending on trait availability (Table S19). We implemented the analysis using DESeq2 (version 1.44.0) with the bulk RNA recommendations (Wald test instead of likelihood ratio test).56 We adjusted for sex, age, median insert size, mean RNA integrity number (RIN), median transcript integrity number (TIN), batch, city of collection, mean GC content, and cell type proportions from the single-nucleus experiment. To test for the possibility of confounding, additional models adjusted for both HOMA-IR and vigorous physical activity. We corrected for multiple testing by applying an FDR threshold of 5% across all gene expression–trait associations for a given trait. No independent filtering was performed when using DESeq2.

Downsampling type 1 fiber gene counts

To approximate the power to detect gene expression–trait associations in other cell types, we downsampled gene counts from Type 1 muscle fiber in additional models. For each cell type comparison, we only included individuals in the downsampled Type 1 analysis who were also included in the analysis for the respective target cell type. To downsample the total UMIs for Type 1 to each target cell type, we multiplied the Type 1 UMIs for each gene (rounded to the nearest integer) by the total UMIs in the target cell type divided by the total UMIs in Type 1 muscle fiber. We tested for differential gene expression by trait in each of the downsampled Type 1 samples using DESeq2 (version 1.44.0) as previously described.

Gene set enrichment analysis by phenotypic trait

We used RNA-Enrich to identify Gene Ontology (GO) terms enriched for genes with higher or lower expression with trait values.36 Briefly, RNA-Enrich models the association between GO term membership and the signed −log10 p value of gene expression–trait association while adjusting for each gene’s mean read count using a logistic regression model. We mapped ENSEMBL IDs to Entrez IDs using the library org.Hs.eg.db version 3.20.0. We acquired GO term definitions using the libraries org.Hs.eg.db version 3.20.0 and GO.db version 3.20.0. We ran models separately for each trait and cell type combination. We considered all GO biological process gene sets (n = 6,486) containing 10–500 genes in at least one dataset (muscle fiber type, total pseudobulk, or bulk tissue). To reduce the potential impact of extreme values on gene set enrichment results, we winsorized all p values < 10-25 to 10-25 prior to running RNA-Enrich (only gene expression–sex associations had p values<10-25 and were winsorized). To assess the independence of results for a given trait, we also ran RNA-Enrich on gene expression–trait associations in a subset of models adjusted for a second trait. We corrected for multiple testing by applying an FDR threshold of 5% across all gene set–trait associations for a given trait and cell type.

Comparison of sets of gene expression–trait and gene set–trait associations

We compared gene expression–trait and gene set–trait associations within each cell type by plotting the signed (by beta coefficient) −log10 p values of association for trait 1 on the x-axis and trait 2 on the y-axis. To quantify these associations, we calculated the Spearman correlation between the signed −log10 p values of association for pairs of traits using the cor.test() function in R, restricting to complete observations. We tested these correlation coefficients against a null hypothesis that the correlation is equal to 0. We corrected for multiple testing using a Bonferroni correction. When testing across all pairwise combinations of eight traits across eight cell types, the significance threshold was set to 0.05/(28×8), where 28 represents the number of unique trait pairs.

We compared gene expression–trait and gene set–trait associations between cell types for the same trait by first plotting the signed −log10 p values of association for cell type 1 on the x-axis and cell type 2 on the y-axis. To quantify these relationships, we calculated the Spearman correlation between the signed −log10 p values of association for pairs of cell types using the cor.test() function in R, restricting to complete observations. We tested these correlation coefficients against a null hypothesis that the correlation is equal to 0. We corrected for multiple testing using a Bonferroni correction. When testing all pairwise comparisons of 12 cell types (including total pseudobulk and bulk tissue) across two traits (HOMA-IR and vigorous physical activity), the significance threshold was set to 0.05/(66×2), where 66 represents the number of unique cell type pairs.

Single-nucleus cell type differential chromatin accessibility by phenotypic traits

We tested single-nucleus cell-type-level chromatin accessibility data for associations with continuous cardiometabolic traits, physical activity, sex (male vs. female), age, and T2D vs. NGT. To generate cell-type-level pseudobulk peak counts, for each cell type, individual, and peak, we summed the fragment counts from all nuclei of a given cell type. Aggregating single-nucleus data through pseudobulking replicates the signal architecture of bulk ATAC-seq architecture while enhancing sensitivity for identifying weak open chromatin regions.66 Although this approach is limited in clusters with <200 nuclei, our dataset significantly exceeds this threshold for all cell types.66

For each cell type, we included only samples with ≥10 nuclei of that cell type. No cell types were excluded from this analysis. We excluded peaks with a mean peak count <1. Across cell types, the number of samples with ≥10 snATAC nuclei ranged from 73 in macrophages to 263 in Type 1 muscle fiber (Table S17). The mean number of ATAC nuclei per sample ranged from 16.8 in macrophages to 273.9 in Type 1 (Table S17). The number of peaks tested ranged from 20,706 to 927,588 (Table S18).

For each cell type, we used a negative binomial model to test for the association between peak counts and each trait. Sample size varied across models depending on the trait availability (Table S20). We ran the analysis using DESeq2 (version 1.44.0) following the single cell recommendations.56 Models adjusted for batch, city of collection, median mitochondrial fraction (across nuclei), transcription start site enrichment, total number of ATAC nuclei, sex (male vs. female), and age. We inverse normalized all continuous covariates to remove the possible effect of extreme values. We corrected for multiple testing by applying an FDR threshold of 5% across all peak–trait associations for a given trait and cell type. No independent filtering was performed when using DESeq2.

Concordance of differential gene expression and chromatin accessibility

To test for directionally consistent association between trait-associated genes and trait-associated promoter-proximal chromatin accessibility regions for one trait (HOMA-IR or vigorous physical activity) at a time, we used snATAC-seq and snRNA-seq data from each muscle fiber type (Type 1, Type 2a, and Type 2x). Note that our snATAC-seq and snRNA-seq data come from different experiments on the same biological samples and thus we cannot directly test for association of gene expression levels and peak accessibility in the same nuclei. In each muscle fiber type, we counted the number of trait-associated peaks (FDR<5%) identified within 1kb upstream of the canonical gene transcription start site (TSS) for each tested gene and trait (GENCODE v.30).55 For each muscle fiber type and trait, we used a logistic regression model to test for the association between the presence of ≥1 peak significantly associated with higher trait values within 1kb upstream of the TSS (independent variable, coded as 1 for ≥1 peak associated with higher trait values; 0 for no trait-associated peak (including those with no peak)) and genes significantly associated with higher trait values (dependent variable, coded as 1 for genes associated with higher trait values; 0 otherwise). We repeated these analyses coding as 1 the peaks and genes associated with lower trait values, and 0 otherwise. We defined Bonferroni-adjusted significance level as p value < 0.05/12.

Footnotes

Supplemental information can be found online at https://doi.org/10.1016/j.isci.2026.117293.

Supplemental information

Document S1. Figures S1–S37 and Tables S1, S2, S4, S5, S7–S10, S12–S14, and S16–20
mmc1.pdf (11.8MB, pdf)
Table S3. Differential cell type abundance by trait, related to Figure 1
mmc2.xlsx (51.6KB, xlsx)
Table S6. Gene expression–trait associations across cell types, total pseudobulk, and bulk tissue, related to Figure 2
mmc3.xlsx (161.6MB, xlsx)
Table S11. Gene set–trait associations across cell types, total pseudobulk, and bulk tissue, related to Figure 4
mmc4.xlsx (52MB, xlsx)
Table S15. Significant peak–trait associations across cell types, related to STAR Methods on chromatin accessibility
mmc5.xlsx (18.1MB, xlsx)

References

  • 1.Colberg S.R., Sigal R.J., Fernhall B., Regensteiner J.G., Blissmer B.J., Rubin R.R., Chasan-Taber L., Albright A.L., Braun B. Exercise and Type 2 Diabetes. Diabetes Care. 2010;33:e147–e167. doi: 10.2337/dc10-9990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.DeFronzo R.A., Tripathy D. Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes. Diabetes Care. 2009;32:S157–S163. doi: 10.2337/dc09-S302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hu G., Lindström J., Valle T.T., Eriksson J.G., Jousilahti P., Silventoinen K., Qiao Q., Tuomilehto J. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch. Intern. Med. 2004;164:892–896. doi: 10.1001/archinte.164.8.892. [DOI] [PubMed] [Google Scholar]
  • 4.Taylor R. Insulin Resistance and Type 2 Diabetes. Diabetes. 2012;61:778–779. doi: 10.2337/db12-0073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.dos Santos J.M., Moreli M.L., Tewari S., Benite-Ribeiro S.A. The effect of exercise on skeletal muscle glucose uptake in type 2 diabetes: An epigenetic perspective. Metabolism. 2015;64:1619–1628. doi: 10.1016/j.metabol.2015.09.013. [DOI] [PubMed] [Google Scholar]
  • 6.Merz K.E., Thurmond D.C. Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake. Compr. Physiol. 2020;10:785–809. doi: 10.1002/cphy.c190029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Distefano G., Goodpaster B.H. Effects of Exercise and Aging on Skeletal Muscle. Cold Spring Harb. Perspect. Med. 2018;8 doi: 10.1101/cshperspect.a029785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Evans P.L., McMillin S.L., Weyrauch L.A., Witczak C.A. Regulation of Skeletal Muscle Glucose Transport and Glucose Metabolism by Exercise Training. Nutrients. 2019;11:2432. doi: 10.3390/nu11102432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liu Y., Schlumberger A., Wirth K., Schmidtbleicher D., Steinacker J.M. Different effects on human skeletal myosin heavy chain isoform expression: strength vs. combination training. J. Appl. Physiol. 1985;94:2282–2288. doi: 10.1152/japplphysiol.00830.2002. [DOI] [PubMed] [Google Scholar]
  • 10.Pillon N.J., Gabriel B.M., Dollet L., Smith J.A.B., Sardón Puig L., Botella J., Bishop D.J., Krook A., Zierath J.R. Transcriptomic profiling of skeletal muscle adaptations to exercise and inactivity. Nat. Commun. 2020;11:470. doi: 10.1038/s41467-019-13869-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Plotkin D.L., Roberts M.D., Haun C.T., Schoenfeld B.J. Muscle Fiber Type Transitions with Exercise Training: Shifting Perspectives. Sports (Basel) 2021;9:127. doi: 10.3390/sports9090127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Frankenberg N.T., Mason S.A., Wadley G.D., Murphy R.M. Skeletal muscle cell-specific differences in type 2 diabetes. Cell. Mol. Life Sci. 2022;79:256. doi: 10.1007/s00018-022-04265-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Oberbach A., Bossenz Y., Lehmann S., Niebauer J., Adams V., Paschke R., Schön M.R., Blüher M., Punkt K. Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes. Diabetes Care. 2006;29:895–900. doi: 10.2337/diacare.29.04.06.dc05-1854. [DOI] [PubMed] [Google Scholar]
  • 14.Stuart C.A., McCurry M.P., Marino A., South M.A., Howell M.E.A., Layne A.S., Ramsey M.W., Stone M.H. Slow-Twitch Fiber Proportion in Skeletal Muscle Correlates With Insulin Responsiveness. J. Clin. Endocrinol. Metab. 2013;98:2027–2036. doi: 10.1210/jc.2012-3876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Talbot J., Maves L. Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease. Wiley Interdiscip. Rev.: Dev. Biol. 2016;5:518–534. doi: 10.1002/wdev.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Møller A.B., Kampmann U., Hedegaard J., Thorsen K., Nordentoft I., Vendelbo M.H., Møller N., Jessen N. Altered gene expression and repressed markers of autophagy in skeletal muscle of insulin resistant patients with type 2 diabetes. Sci. Rep. 2017;7 doi: 10.1038/srep43775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Parikh H.M., Elgzyri T., Alibegovic A., Hiscock N., Ekström O., Eriksson K.F., Vaag A., Groop L.C., Ström K., Hansson O. Relationship between insulin sensitivity and gene expression in human skeletal muscle. BMC Endocr. Disord. 2021;21:32. doi: 10.1186/s12902-021-00687-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Scott L.J., Erdos M.R., Huyghe J.R., Welch R.P., Beck A.T., Wolford B.N., Chines P.S., Didion J.P., Narisu N., Stringham H.M., et al. The genetic regulatory signature of type 2 diabetes in human skeletal muscle. Nat. Commun. 2016;7 doi: 10.1038/ncomms11764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sreekumar R., Halvatsiotis P., Schimke J.C., Nair K.S. Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment. Diabetes. 2002;51:1913–1920. doi: 10.2337/diabetes.51.6.1913. [DOI] [PubMed] [Google Scholar]
  • 20.Taylor D.L., Jackson A.U., Narisu N., Hemani G., Erdos M.R., Chines P.S., Swift A., Idol J., Didion J.P., Welch R.P., et al. Integrative analysis of gene expression, DNA methylation, physiological traits, and genetic variation in human skeletal muscle. Proc. Natl. Acad. Sci. USA. 2019;116:10883–10888. doi: 10.1073/pnas.1814263116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003;34:267–273. doi: 10.1038/ng1180. [DOI] [PubMed] [Google Scholar]
  • 22.Li X., Wang C.-Y. From bulk, single-cell to spatial RNA sequencing. Int. J. Oral Sci. 2021;13:36. doi: 10.1038/s41368-021-00146-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Grindberg R.V., Yee-Greenbaum J.L., McConnell M.J., Novotny M., O'Shaughnessy A.L., Lambert G.M., Araúzo-Bravo M.J., Lee J., Fishman M., Robbins G.E., et al. RNA-sequencing from single nuclei. Proc. Natl. Acad. Sci. USA. 2013;110:19802–19807. doi: 10.1073/pnas.1319700110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kim N., Kang H., Jo A., Yoo S.-A., Lee H.-O. Perspectives on single-nucleus RNA sequencing in different cell types and tissues. J. Pathol. Transl. Med. 2023;57:52–59. doi: 10.4132/jptm.2022.12.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Jew B., Alvarez M., Rahmani E., Miao Z., Ko A., Garske K.M., Sul J.H., Pietiläinen K.H., Pajukanta P., Halperin E. Accurate estimation of cell composition in bulk expression through robust integration of single-cell information. Nat. Commun. 2020;11:1971. doi: 10.1038/s41467-020-15816-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rubenstein A.B., Smith G.R., Zhang Z., Chen X., Chambers T.L., Ruf-Zamojski F., Mendelev N., Cheng W.S., Zamojski M., Amper M.A.S., et al. Integrated single-cell multiome analysis reveals muscle fiber-type gene regulatory circuitry modulated by endurance exercise. Genome Res. 2025;35:1664–1677. doi: 10.1101/gr.280051.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Hansen M., Grothen J.E.R., Karlsen A., Martinez J.M., Sidiropoulos N., Helge J.W., Pedersen T.Å., Dela F. The skeletal muscle response to high-intensity training assessed by single-nucleus RNA-sequencing is blunted in individuals with type 2 diabetes. J. Physiol. 2025;603:3357–3377. doi: 10.1113/JP288368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883. [DOI] [PubMed] [Google Scholar]
  • 29.Hakola L., Komulainen P., Hassinen M., Savonen K., Litmanen H., Lakka T.A., Rauramaa R. Cardiorespiratory fitness in aging men and women: the DR’s EXTRA study. Scand. J. Med. Sci. Sports. 2011;21:679–687. doi: 10.1111/j.1600-0838.2010.01127.x. [DOI] [PubMed] [Google Scholar]
  • 30.Laaksonen D.E., Lindström J., Lakka T.A., Eriksson J.G., Niskanen L., Wikström K., Aunola S., Keinänen-Kiukaanniemi S., Laakso M., Valle T.T., et al. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes. 2005;54:158–165. doi: 10.2337/diabetes.54.1.158. [DOI] [PubMed] [Google Scholar]
  • 31.Lakka T.A., Venäläinen J.M., Rauramaa R., Salonen R., Tuomilehto J., Salonen J.T. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N. Engl. J. Med. 1994;330:1549–1554. doi: 10.1056/NEJM199406023302201. [DOI] [PubMed] [Google Scholar]
  • 32.World Health Organization, International Diabetes Federation . World Health Organization; 2006. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO/IDF Consultation.https://www.who.int/publications/i/item/definition-and-diagnosis-of-diabetes-mellitus-and-intermediate-hyperglycaemia [Google Scholar]
  • 33.Silva C.d.C.d., Zambon M.P., Vasques A.C.J., Camilo D.F., Antonio M.Â.R.d.G.M., Geloneze B. The threshold value for identifying insulin resistance (HOMA-IR) in an admixed adolescent population: A hyperglycemic clamp validated study. Arch. Endocrinol. Metab. 2022;67:119–125. doi: 10.20945/2359-3997000000533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Varshney A., Manickam N., Orchard P., Tovar A., Ventresca C., Zhang Z., Feng F., Mears J., Erdos M.R., Narisu N., et al. Population-scale skeletal muscle single-nucleus multi-omic profiling reveals extensive context specific genetic regulation. bioRxiv. 2024 doi: 10.1101/2023.12.15.571696. [DOI] [Google Scholar]
  • 35.Hanks S.C., Mauger A.S., Varshney A., Ciotlos D.L., Manickam N., Narisu N., Shumway A.J., Orchard P., Erdos M.R., Sweeney M.D., et al. Extensive differential gene expression and regulation by sex in human skeletal muscle. Cell Genom. 2025;5 doi: 10.1016/j.xgen.2025.100915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lee C., Patil S., Sartor M.A. RNA-Enrich: a cut-off free functional enrichment testing method for RNA-seq with improved detection power. Bioinformatics. 2016;32:1100–1102. doi: 10.1093/bioinformatics/btv694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Yaribeygi H., Maleki M., Sathyapalan T., Jamialahmadi T., Sahebkar A. Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence. J. Diabetes Res. 2021;2021 doi: 10.1155/2021/7796727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Methenitis S., Nomikos T., Kontou E., Kiourelli K.M., Papadimas G., Papadopoulos C., Terzis G. Skeletal muscle fiber composition may modify the effect of nutrition on body composition in young females. Nutr. Metab. Cardiovasc. Dis. 2023;33:817–825. doi: 10.1016/j.numecd.2022.12.027. [DOI] [PubMed] [Google Scholar]
  • 39.Serrano N., Hyatt J.-P.K., Houmard J.A., Murgia M., Katsanos C.S. Muscle fiber phenotype: a culprit of abnormal metabolism and function in skeletal muscle of humans with obesity. Am. J. Physiol. Endocrinol. Metab. 2023;325:E723–E733. doi: 10.1152/ajpendo.00190.2023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Barthelson R.A., Lambert G.M., Vanier C., Lynch R.M., Galbraith D.W. Comparison of the contributions of the nuclear and cytoplasmic compartments to global gene expression in human cells. BMC Genom. 2007;8:340. doi: 10.1186/1471-2164-8-340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Köhler A., Hurt E. Exporting RNA from the nucleus to the cytoplasm. Nat. Rev. Mol. Cell Biol. 2007;8:761–773. doi: 10.1038/nrm2255. [DOI] [PubMed] [Google Scholar]
  • 42.Wickramasinghe V.O., Laskey R.A. Control of mammalian gene expression by selective mRNA export. Nat. Rev. Mol. Cell Biol. 2015;16:431–442. doi: 10.1038/nrm4010. [DOI] [PubMed] [Google Scholar]
  • 43.Kiani K., Sanford E.M., Goyal Y., Raj A. Changes in chromatin accessibility are not concordant with transcriptional changes for single-factor perturbations. Mol. Syst. Biol. 2022;18 doi: 10.15252/msb.202210979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Chia C.W., Egan J.M., Ferrucci L. Age-related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk. Circ. Res. 2018;123:886–904. doi: 10.1161/CIRCRESAHA.118.312806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Kalyani R.R., Egan J.M. Diabetes and Altered Glucose Metabolism with Aging. Endocrinol. Metab. Clin. North Am. 2013;42:333–347. doi: 10.1016/j.ecl.2013.02.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Johannsen D.L., DeLany J.P., Frisard M.I., Welsch M.A., Rowley C.K., Fang X., Jazwinski S.M., Ravussin E., Louisiana Healthy Aging Study Physical activity in aging: Comparison among young, aged, and nonagenarian individuals. J. Appl. Physiol. 2008;105:495–501. doi: 10.1152/japplphysiol.90450.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Su J., Ekman C., Oskolkov N., Lahti L., Ström K., Brazma A., Groop L., Rung J., Hansson O. A novel atlas of gene expression in human skeletal muscle reveals molecular changes associated with aging. Skelet. Muscle. 2015;5:35. doi: 10.1186/s13395-015-0059-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Fritz M.S., MacKinnon D.P. Required Sample Size to Detect the Mediated Effect. Psychol. Sci. 2007;18:233–239. doi: 10.1111/j.1467-9280.2007.01882.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Hayes A.F. 3rd ed. The Guilford Press; 2022. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. [Google Scholar]
  • 50.Liu Y., Beyer A., Aebersold R. On the Dependency of Cellular Protein Levels on mRNA Abundance. Cell. 2016;165:535–550. doi: 10.1016/j.cell.2016.03.014. [DOI] [PubMed] [Google Scholar]
  • 51.Maier T., Güell M., Serrano L. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009;583:3966–3973. doi: 10.1016/j.febslet.2009.10.036. [DOI] [PubMed] [Google Scholar]
  • 52.Stastna M., Van Eyk J.E. Analysis of protein isoforms: can we do it better? Proteomics. 2012;12:2937–2948. doi: 10.1002/pmic.201200161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Lee T.I., Young R.A. Transcriptional Regulation and Its Misregulation in Disease. Cell. 2013;152:1237–1251. doi: 10.1016/j.cell.2013.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Keshet Y., Seger R. In: MAP Kinase Signaling Protocols. Second Edition. Seger R., editor. Humana Press; 2010. The MAP Kinase Signaling Cascades: A System of Hundreds of Components Regulates a Diverse Array of Physiological Functions; pp. 3–38. [DOI] [PubMed] [Google Scholar]
  • 55.Harrow J., Frankish A., Gonzalez J.M., Tapanari E., Diekhans M., Kokocinski F., Aken B.L., Barrell D., Zadissa A., Searle S., et al. GENCODE: The reference human genome annotation for The ENCODE Project. Genome Res. 2012;22:1760–1774. doi: 10.1101/gr.135350.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Love M.I., Huber W., Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ainsworth B.E., Haskell W.L., Herrmann S.D., Meckes N., Bassett D.R., Jr., Tudor-Locke C., Greer J.L., Vezina J., Whitt-Glover M.C., Leon A.S. Compendium of Physical Activities: a second update of codes and MET values. Med. Sci. Sports Exerc. 2011;43:1575–1581. doi: 10.1249/MSS.0b013e31821ece12. [DOI] [PubMed] [Google Scholar]
  • 58.Kaminow B., Yunusov D., Dobin A. STARsolo: accurate, fast and versatile mapping/quantification of single-cell and single-nucleus RNA-seq data. 2021. bioRxiv. 2021 doi: 10.1101/2021.05.05.442755. Preprint at. [DOI] [Google Scholar]
  • 59.Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754–1760. doi: 10.1093/bioinformatics/btp324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Yang S., Corbett S.E., Koga Y., Wang Z., Johnson W.E., Yajima M., Campbell J.D. Decontamination of ambient RNA in single-cell RNA-seq with DecontX. Genome Biol. 2020;21:57. doi: 10.1186/s13059-020-1950-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Liu J., Gao C., Sodicoff J., Kozareva V., Macosko E.Z., Welch J.D. Jointly Defining Cell Types from Multiple Single-Cell Datasets Using LIGER. Nat. Protoc. 2020;15:3632–3662. doi: 10.1038/s41596-020-0391-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Gao C., Liu J., Kriebel A.R., Preissl S., Luo C., Castanon R., Sandoval J., Rivkin A., Nery J.R., Behrens M.M., et al. Iterative single-cell multi-omic integration using online learning. Nat. Biotechnol. 2021;39:1000–1007. doi: 10.1038/s41587-021-00867-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Beshnova D.A., Cherstvy A.G., Vainshtein Y., Teif V.B. Regulation of the Nucleosome Repeat Length In Vivo by the DNA Sequence, Protein Concentrations and Long-Range Interactions. PLoS Comput. Biol. 2014;10 doi: 10.1371/journal.pcbi.1003698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zhang Y., Liu T., Meyer C.A., Eeckhoute J., Johnson D.S., Bernstein B.E., Nusbaum C., Myers R.M., Brown M., Li W., Liu X.S. Model-based Analysis of ChIP-Seq (MACS) Genome Biol. 2008;9 doi: 10.1186/gb-2008-9-9-r137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Venables W.N., Ripley B.D. 4th ed. Springer; 2002. Modern Applied Statistics with S. [Google Scholar]
  • 66.Gur E.R., Hughes J.R. scATAC-seq generates more accurate and complete regulatory maps than bulk ATAC-seq. Sci. Rep. 2025;15:3665. doi: 10.1038/s41598-025-87351-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Document S1. Figures S1–S37 and Tables S1, S2, S4, S5, S7–S10, S12–S14, and S16–20
mmc1.pdf (11.8MB, pdf)
Table S3. Differential cell type abundance by trait, related to Figure 1
mmc2.xlsx (51.6KB, xlsx)
Table S6. Gene expression–trait associations across cell types, total pseudobulk, and bulk tissue, related to Figure 2
mmc3.xlsx (161.6MB, xlsx)
Table S11. Gene set–trait associations across cell types, total pseudobulk, and bulk tissue, related to Figure 4
mmc4.xlsx (52MB, xlsx)
Table S15. Significant peak–trait associations across cell types, related to STAR Methods on chromatin accessibility
mmc5.xlsx (18.1MB, xlsx)

Data Availability Statement

  • •

    The bulk RNA-seq, snRNA-seq, snATAC-seq, and phenotype data have been deposited in dbGaP: phs001048.v4.p1 and are publicly available as of the date of publication. All original code and an extended Table S15 with all peak–trait association results have been deposited to Zenodo and are available as of the date of publication: https://doi.org/10.5281/zenodo.17742578.

  • •

    Any additional information required to reanalyze the data reported in this paper is available from the lead contact upon request.


Articles from iScience are provided here courtesy of Elsevier

RESOURCES